A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
Not specified
Study Completion Date
August 31, 1992
Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG
Interferon alfa-2b
DRUG
Zidovudine
DRUG
Sargramostim
Trial Locations (1)
10021
Mem Sloan - Kettering Cancer Ctr, New York
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000694 - A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter